Adverum Biotechnologies, Inc. financial reports, Adverum Biotechnologies, Inc. annual revenue in 2024. When does Adverum Biotechnologies, Inc. report revenue?
Adverum Biotechnologies, Inc. total revenue, net income and dynamics of changes in US dollar today
Adverum Biotechnologies, Inc. current income in US dollar. Net revenue of Adverum Biotechnologies, Inc. on 31/03/2021 amounted to 7 500 000 $. Here are the main financial indicators of Adverum Biotechnologies, Inc.. The value of "net income" Adverum Biotechnologies, Inc. on the graph is displayed in blue. The value of the "total revenue of Adverum Biotechnologies, Inc." on the chart is marked in yellow. The value of all Adverum Biotechnologies, Inc. assets on the graph is shown in green.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
7 500 000 $
-
-28 436 000 $
-
31/12/2020
0 $
-100 % ↓
-37 632 000 $
-
30/09/2020
0 $
-100 % ↓
-27 769 000 $
-
30/06/2020
0 $
-
-29 200 000 $
-
30/09/2019
250 000 $
-
-16 118 000 $
-
30/06/2019
0 $
-
-14 954 000 $
-
31/03/2019
0 $
-
-14 489 000 $
-
31/12/2018
70 000 $
-
-15 659 000 $
-
Show:
to
Adverum Biotechnologies, Inc. financial report charts
The dates of the latest financial statements of Adverum Biotechnologies, Inc.: 31/12/2018, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of Adverum Biotechnologies, Inc. is available online for such a date - 31/03/2021. Gross profit Adverum Biotechnologies, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Adverum Biotechnologies, Inc. is -12 480 000 $
Adverum Biotechnologies, Inc. quarterly report dates
Cost of revenue Adverum Biotechnologies, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Adverum Biotechnologies, Inc. is 19 980 000 $ Total revenue Adverum Biotechnologies, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Adverum Biotechnologies, Inc. is 7 500 000 $ Operating income Adverum Biotechnologies, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Adverum Biotechnologies, Inc. is -28 643 000 $
Net income Adverum Biotechnologies, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Adverum Biotechnologies, Inc. is -28 436 000 $ Current assets Adverum Biotechnologies, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Adverum Biotechnologies, Inc. is 409 855 000 $ Total assets Adverum Biotechnologies, Inc. refers to the total amount of assets owned by a person or entity. Total assets Adverum Biotechnologies, Inc. is 461 551 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-12 480 000 $
-22 728 000 $
-16 653 000 $
-19 177 000 $
-9 694 000 $
-8 970 000 $
-10 131 000 $
-11 572 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
19 980 000 $
22 728 000 $
16 653 000 $
19 177 000 $
9 944 000 $
8 970 000 $
10 131 000 $
11 642 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
7 500 000 $
-
-
-
250 000 $
-
-
70 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
250 000 $
-
-
70 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-28 643 000 $
-36 380 000 $
-28 004 000 $
-29 775 000 $
-17 083 000 $
-16 102 000 $
-15 707 000 $
-15 959 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-28 436 000 $
-37 632 000 $
-27 769 000 $
-29 200 000 $
-16 118 000 $
-14 954 000 $
-14 489 000 $
-15 659 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
9 944 000 $
8 970 000 $
8 970 000 $
8 970 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
36 143 000 $
36 380 000 $
28 004 000 $
29 775 000 $
17 333 000 $
16 102 000 $
15 707 000 $
16 029 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
409 855 000 $
434 438 000 $
459 700 000 $
282 681 000 $
167 602 000 $
180 561 000 $
193 137 000 $
208 754 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
461 551 000 $
482 567 000 $
507 711 000 $
331 176 000 $
205 525 000 $
209 884 000 $
221 047 000 $
213 495 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
45 422 000 $
62 424 000 $
72 696 000 $
27 359 000 $
73 171 000 $
97 808 000 $
144 107 000 $
154 949 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
17 746 000 $
10 149 000 $
10 610 000 $
10 719 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
41 311 000 $
32 144 000 $
32 904 000 $
12 328 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
20.10 %
15.32 %
14.89 %
5.77 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
414 820 000 $
434 347 000 $
464 712 000 $
282 563 000 $
164 214 000 $
177 740 000 $
188 143 000 $
201 167 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-9 530 000 $
-11 588 000 $
-13 217 000 $
-12 730 000 $
Last revenue report of Adverum Biotechnologies, Inc. was 31/03/2021. According to last financial report total revenue in Adverum Biotechnologies, Inc. was 7 500 000 US dollar and changed by -100% since last year. Net income in Adverum Biotechnologies, Inc. was -28 436 000 $ in last quartal, net income changes to 0%.
Current cash Adverum Biotechnologies, Inc. - the sum of all of the cash a company has on the date of report. Current cash Adverum Biotechnologies, Inc. is 45 422 000 $
Adverum Biotechnologies, Inc. stocks data
ADVM stock price
Adverum Biotechnologies, Inc. stock price today, ADVM stock quote.
